2024 Q2 Form 10-K Financial Statement

#000136836524000060 Filed on April 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $3.699M $226.0K $4.402M
YoY Change 16.8% -86.13% -62.27%
Cost Of Revenue $2.925M $103.0K $3.323M
YoY Change 16.49% -96.26% -70.67%
Gross Profit $774.0K $123.0K $1.079M
YoY Change 17.99% -110.92% 222.09%
Gross Profit Margin 20.92% 54.42% 24.51%
Selling, General & Admin $3.563M $4.769M $14.78M
YoY Change -1.87% 14.47% -23.69%
% of Gross Profit 460.34% 3877.24% 1369.97%
Research & Development $366.0K $389.0K $1.893M
YoY Change -35.45% -64.54% -9.9%
% of Gross Profit 47.29% 316.26% 175.44%
Depreciation & Amortization $105.0K $285.0K
YoY Change 133.33% 71.69%
% of Gross Profit 85.37% 26.41%
Operating Expenses $3.929M $5.265M $16.68M
YoY Change -6.41% -0.81% -22.34%
Operating Profit -$3.213M -$5.142M -$17.16M
YoY Change -18.84% -20.08% -19.44%
Interest Expense -$1.903M $4.294M
YoY Change -12.3% -29.29%
% of Operating Profit
Other Income/Expense, Net -$2.046M -$6.000K -$11.99M
YoY Change 6.84% -300.0% -64.94%
Pretax Income -$7.939M -$29.15M
YoY Change -7.7% -47.48%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.259M -$7.939M -$29.15M
YoY Change -10.47% -7.7% -47.47%
Net Earnings / Revenue -142.17% -3512.83% -662.13%
Basic Earnings Per Share -$0.12 -$1.74
Diluted Earnings Per Share -$0.12 -$0.38 -$1.74
COMMON SHARES
Basic Shares Outstanding 42.56M shares 20.93M shares 16.74M shares
Diluted Shares Outstanding 45.68M shares 16.74M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.0K $145.0K
YoY Change 178.85% 178.85%
Cash & Equivalents $438.0K $145.0K $145.0K
Short-Term Investments
Other Short-Term Assets $0.00 $7.111M
YoY Change -100.0% -19.32%
Inventory $646.0K $750.0K $750.0K
Prepaid Expenses $369.0K $339.0K
Receivables $4.361M $1.287M $1.287M
Other Receivables $147.0K $147.0K
Total Short-Term Assets $5.937M $9.440M $9.440M
YoY Change -43.27% -23.18% -23.18%
LONG-TERM ASSETS
Property, Plant & Equipment $634.0K $189.0K $706.0K
YoY Change -55.41% -88.88% -62.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $71.00K $90.00K $90.00K
YoY Change -62.03% -66.54% -66.54%
Total Long-Term Assets $7.367M $796.0K $796.0K
YoY Change 207.98% -62.94% -62.94%
TOTAL ASSETS
Total Short-Term Assets $5.937M $9.440M $9.440M
Total Long-Term Assets $7.367M $796.0K $796.0K
Total Assets $13.30M $10.24M $10.24M
YoY Change 3.47% -29.09% -29.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.348M $9.348M
YoY Change -2.65% -2.65%
Accrued Expenses $13.20M $11.92M $9.162M
YoY Change 61.23% 65.07% 91.67%
Deferred Revenue $418.0K $570.0K
YoY Change -0.48% 85.06%
Short-Term Debt $16.46M $16.46M
YoY Change 12.71% 12.71%
Long-Term Debt Due $10.03M $10.03M
YoY Change 430.29% 430.29%
Total Short-Term Liabilities $59.47M $49.54M $49.54M
YoY Change 45.45% 42.34% 42.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $286.0K $286.0K
YoY Change 410.71% 410.71%
Total Long-Term Liabilities $286.0K $286.0K
YoY Change 410.71% 410.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.47M $49.54M $49.54M
Total Long-Term Liabilities $286.0K $286.0K
Total Liabilities $59.65M $49.83M $49.83M
YoY Change 44.48% 42.93% 42.93%
SHAREHOLDERS EQUITY
Retained Earnings -$436.7M -$417.7M
YoY Change 8.49% 7.5%
Common Stock $50.00K $22.00K
YoY Change 194.12% 83.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$46.30M -$39.60M -$39.59M
YoY Change
Total Liabilities & Shareholders Equity $13.30M $10.24M $10.24M
YoY Change 3.47% -29.09% -29.09%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$5.259M -$7.939M -$29.15M
YoY Change -10.47% -7.7% -47.47%
Depreciation, Depletion And Amortization $105.0K $285.0K
YoY Change 133.33% 71.69%
Cash From Operating Activities -$1.375M -$10.46M
YoY Change -53.87% -37.08%
INVESTING ACTIVITIES
Capital Expenditures $21.00K $51.00K
YoY Change -93.77% -88.62%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$21.00K -$51.00K
YoY Change -93.77% -101.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.269M $10.60M
YoY Change -57.62% -552.95%
NET CHANGE
Cash From Operating Activities -1.375M -$10.46M
Cash From Investing Activities -21.00K -$51.00K
Cash From Financing Activities 1.269M $10.60M
Net Change In Cash -127.0K $93.00K
YoY Change -60.8% -100.66%
FREE CASH FLOW
Cash From Operating Activities -$1.375M -$10.46M
Capital Expenditures $21.00K $51.00K
Free Cash Flow -$1.396M -$10.51M
YoY Change -57.93% -38.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity File Number
EntityFileNumber
001-33720
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89106
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 us-gaap Interest Expense
InterestExpense
4294000 usd
CY2022 us-gaap Interest Expense
InterestExpense
6073000 usd
CY2022 mark Finance Cost On Liability Related To Convertible Debenture
FinanceCostOnLiabilityRelatedToConvertibleDebenture
1422000 usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001368365
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Entity Registrant Name
EntityRegistrantName
Remark Holdings, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1135689
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
800 S. Commerce St.
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023 dei City Area Code
CityAreaCode
702
CY2023 dei Local Phone Number
LocalPhoneNumber
701-9514
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
15700000 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42559701 shares
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
572
CY2023 dei Auditor Name
AuditorName
Weinberg & Company, P.A.
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1287000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3091000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
750000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
308000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
6644000 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
7463000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
614000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1374000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9440000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12288000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
189000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1699000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
517000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
180000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
269000 usd
CY2023Q4 us-gaap Assets
Assets
10236000 usd
CY2022Q4 us-gaap Assets
Assets
14436000 usd
CY2023Q4 mark Convertible Debenture Current
ConvertibleDebentureCurrent
10033000 usd
CY2022Q4 mark Convertible Debenture Current
ConvertibleDebentureCurrent
1892000 usd
CY2023Q4 mark Accrued Liabilities Delinquent Payroll Taxes Current
AccruedLiabilitiesDelinquentPayrollTaxesCurrent
495000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11921000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7222000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
570000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
308000 usd
CY2023Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
16463000 usd
CY2022Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
14607000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49540000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34805000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
286000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
49826000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
34861000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22038855 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22038855 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11539564 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11539564 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
22000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
379244000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
368945000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1186000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-859000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-417670000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-388523000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-39590000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-20425000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10236000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14436000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4402000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11666000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
3323000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
11331000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1408000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
971000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1893000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2101000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13374000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18399000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
285000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
166000 usd
CY2023 mark Finance Cost On Liability Related To Convertible Debenture
FinanceCostOnLiabilityRelatedToConvertibleDebenture
7672000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-26356000 usd
CY2023 mark Other Nonoperating Gain Loss
OtherNonoperatingGainLoss
-20000 usd
CY2022 mark Other Nonoperating Gain Loss
OtherNonoperatingGainLoss
-339000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11986000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34190000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29147000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55492000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29147000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-55483000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-327000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-589000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29474000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-56072000 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16741677 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16741677 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10630771 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10630771 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.74
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.74
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.22
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.22
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31034000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
-5000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-55483000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2104000 usd
CY2022 mark Stock Issued During Period Value New Issues Excluding Acquisitions
StockIssuedDuringPeriodValueNewIssuesExcludingAcquisitions
500000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2004000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-589000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-20425000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29147000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
178000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10131000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-327000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-39590000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29147000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-55483000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
285000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
166000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
157000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1697000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2189000 usd
CY2023 mark Cost Of Extending Note Payable
CostOfExtendingNotePayable
750000 usd
CY2022 mark Cost Of Extending Note Payable
CostOfExtendingNotePayable
283000 usd
CY2023 mark Finance Cost On Liability Related To Convertible Debenture
FinanceCostOnLiabilityRelatedToConvertibleDebenture
7672000 usd
CY2022 mark Finance Cost On Liability Related To Convertible Debenture
FinanceCostOnLiabilityRelatedToConvertibleDebenture
1422000 usd
CY2023 mark Accrued Interest Included In Note Payable
AccruedInterestIncludedInNotePayable
1139000 usd
CY2022 mark Accrued Interest Included In Note Payable
AccruedInterestIncludedInNotePayable
0 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
500000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-26356000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1280000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1729000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2882000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-193000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
182000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
319000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3650000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
260000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1033000 usd
CY2023 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-818000 usd
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
6874000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-501000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4213000 usd
CY2023 mark Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
340000 usd
CY2022 mark Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4575000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1745000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
281000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-251000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
231000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
37000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10455000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16616000 usd
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
6332000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
448000 usd
CY2023 us-gaap Payments For Software
PaymentsForSoftware
0 usd
CY2022 us-gaap Payments For Software
PaymentsForSoftware
1063000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4821000 usd
CY2023 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
8100000 usd
CY2022 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
0 usd
CY2023 mark Proceeds From Obligations To Issue Common Stock Debentures
ProceedsFromObligationsToIssueCommonStockDebentures
2500000 usd
CY2022 mark Proceeds From Obligations To Issue Common Stock Debentures
ProceedsFromObligationsToIssueCommonStockDebentures
2500000 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
203000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1437000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3256000 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
33000 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
6217000 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1405000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2082000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10599000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2340000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14135000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14187000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
145000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1579000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
3238000 usd
CY2023 mark Non Cash Or Part Non Cash Issuance Of Common Stock
NonCashOrPartNonCashIssuanceOfCommonStock
0 usd
CY2022 mark Non Cash Or Part Non Cash Issuance Of Common Stock
NonCashOrPartNonCashIssuanceOfCommonStock
2804000 usd
CY2023 mark Noncash Or Part Noncash Issuance Of Common Stock Pursuant To Debenture Transaction
NoncashOrPartNoncashIssuanceOfCommonStockPursuantToDebentureTransaction
10131000 usd
CY2022 mark Noncash Or Part Noncash Issuance Of Common Stock Pursuant To Debenture Transaction
NoncashOrPartNoncashIssuanceOfCommonStockPursuantToDebentureTransaction
0 usd
CY2023 mark Noncash Or Part Noncash Transfer Of Marketable Securities To Partially Settle Debt
NoncashOrPartNoncashTransferOfMarketableSecuritiesToPartiallySettleDebt
0 usd
CY2022 mark Noncash Or Part Noncash Transfer Of Marketable Securities To Partially Settle Debt
NoncashOrPartNoncashTransferOfMarketableSecuritiesToPartiallySettleDebt
9662000 usd
CY2023 mark Noncash Or Part Noncash Reclassifications Of Warrant Liability To Equity
NoncashOrPartNoncashReclassificationsOfWarrantLiabilityToEquity
233000 usd
CY2022 mark Noncash Or Part Noncash Reclassifications Of Warrant Liability To Equity
NoncashOrPartNoncashReclassificationsOfWarrantLiabilityToEquity
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-39600000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10500000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100000 usd
CY2023Q4 mark Accrued Liabilities Delinquent Payroll Taxes Current
AccruedLiabilitiesDelinquentPayrollTaxesCurrent
500000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, deferred cost of revenue, share-based compensation, deferred income taxes, and inventory reserve, among other items.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods.</span></div>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52000 usd
CY2023 mark Contract With Customer Term Of Contract
ContractWithCustomerTermOfContract
P1Y
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2200000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2200000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4402000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11666000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4402000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11666000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 usd
CY2022 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 usd
CY2023 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7063000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7213000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5776000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4122000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1287000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3091000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
6600000 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
7500000 usd
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2700000 usd
CY2023 mark Repayments To Other Vendors
RepaymentsToOtherVendors
2500000 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
147000 usd
CY2022Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
23000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
339000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1144000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
128000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
201000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
614000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1374000 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
200000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5698000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7928000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5509000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6229000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
189000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1699000 usd
CY2023 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
300000 usd
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
200000 usd
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
800000 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
200000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
394000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
287000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
631000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1343000 usd
CY2023 us-gaap Lease Cost
LeaseCost
1025000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1630000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
400000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.13
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
340000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
249000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
63000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
652000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
574000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
288000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
286000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
574000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6121000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11653000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5459000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-10611000 usd
CY2023 mark Effective Income Tax Rate Reconciliation Finance Cost Of Equity Line Of Credit Amount
EffectiveIncomeTaxRateReconciliationFinanceCostOfEquityLineOfCreditAmount
-1612000 usd
CY2022 mark Effective Income Tax Rate Reconciliation Finance Cost Of Equity Line Of Credit Amount
EffectiveIncomeTaxRateReconciliationFinanceCostOfEquityLineOfCreditAmount
0 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-27000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-883000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
-61000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
-280000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
90000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
123000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-70000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
42000 usd
CY2023 mark Effective Income Tax Rate Reconciliation Increase Decrease In Deferred Assets Amount
EffectiveIncomeTaxRateReconciliationIncreaseDecreaseInDeferredAssetsAmount
476000 usd
CY2022 mark Effective Income Tax Rate Reconciliation Increase Decrease In Deferred Assets Amount
EffectiveIncomeTaxRateReconciliationIncreaseDecreaseInDeferredAssetsAmount
-404000 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
420000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-209000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-24202000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-49297000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4945000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-6195000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29147000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55492000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
48666000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42744000 usd
CY2023Q4 mark Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
2731000 usd
CY2022Q4 mark Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
2371000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7879000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7865000 usd
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
46000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
33000 usd
CY2023Q4 mark Deferred Tax Assets Business Interest Limitation
DeferredTaxAssetsBusinessInterestLimitation
3036000 usd
CY2022Q4 mark Deferred Tax Assets Business Interest Limitation
DeferredTaxAssetsBusinessInterestLimitation
4294000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1994000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1133000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
64352000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
58440000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
64352000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58440000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3221000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1448000 usd
CY2023Q4 mark Accrued Liabilities Delinquent Payroll Taxes Current
AccruedLiabilitiesDelinquentPayrollTaxesCurrent
495000 usd
CY2022Q4 mark Accrued Liabilities Delinquent Payroll Taxes Current
AccruedLiabilitiesDelinquentPayrollTaxesCurrent
0 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1570000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
769000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3577000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2393000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
2138000 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
2234000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
288000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
138000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
11000 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
32000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
621000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
208000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11921000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7222000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
156000 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
189000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
16463000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
14607000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1600000 usd
CY2022 mark Finance Cost On Liability Related To Convertible Debenture
FinanceCostOnLiabilityRelatedToConvertibleDebenture
1400000 usd
CY2023Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
100000 usd
CY2023Q4 mark Registration Rights Agreement Payment Of Penalty Liability
RegistrationRightsAgreementPaymentOfPenaltyLiability
200000 usd
CY2023Q4 mark Registration Rights Agreement Accrued Penalty Liability Current
RegistrationRightsAgreementAccruedPenaltyLiabilityCurrent
800000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1697000 usd
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
206250 shares
CY2021Q4 mark Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Aggregate Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedAggregateWeightedAverageGrantDateFairValue
2063000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
160100 shares
CY2022 mark Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateWeightedAverageGrantDateFairValue
1852000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
6200 shares
CY2022 mark Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Options Forfeited Aggregate Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedAggregateWeightedAverageGrantDateFairValue
72000 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
76950 shares
CY2022Q4 mark Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Aggregate Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedAggregateWeightedAverageGrantDateFairValue
529000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023 mark Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Granted Aggregate Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantedAggregateWeightedAverageGrantDateFairValue
0 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
56853 shares
CY2023 mark Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateWeightedAverageGrantDateFairValue
490000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0 shares
CY2023 mark Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Options Forfeited Aggregate Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedAggregateWeightedAverageGrantDateFairValue
0 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
20097 shares
CY2023Q4 mark Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Aggregate Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedAggregateWeightedAverageGrantDateFairValue
31000 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2020Q3 mark Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue
6300000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
157000 usd

Files In Submission

Name View Source Status
0001368365-24-000060-index-headers.html Edgar Link pending
0001368365-24-000060-index.html Edgar Link pending
0001368365-24-000060.txt Edgar Link pending
0001368365-24-000060-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mark-20231231.htm Edgar Link pending
mark-20231231.xsd Edgar Link pending
mark-20231231_g1.jpg Edgar Link pending
mark-20231231_g2.jpg Edgar Link pending
mark_2023xform10kxex211.htm Edgar Link pending
mark_2023xform10kxex231.htm Edgar Link pending
mark_2023xformx10kxex311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mark-20231231_cal.xml Edgar Link unprocessable
mark-20231231_def.xml Edgar Link unprocessable
mark-20231231_lab.xml Edgar Link unprocessable
mark-20231231_pre.xml Edgar Link unprocessable
mark-20231231_htm.xml Edgar Link completed
mark_2023xformx10kxex312.htm Edgar Link pending
mark_2023xformx10kxex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending